A grid style radiation is tested on brain tumor cells in the lab
Original title: Spatially fractionated mini-GRID radiotherapy differentially modulates radiation-induced senescence in murine glioma and normal cells.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done on cells in a dish, not in people.
The short version
In lab dishes, a new way of aiming radiation killed tumor cells while leaving fewer damaged, worn out cells behind.
What was studied. Researchers compared regular radiation with a grid style radiation called mini-GRID. They tested it on rat brain tumor cells, on brain support cells, and on mouse cells grown in the lab.
What they found. Regular radiation at a high dose of 20 Gy left many tumor cells alive but worn out and damaged. The grid radiation cut the number of tumor cells about the same amount. But it left far fewer cells in that worn out, damaged state. In the normal cells, the two kinds of radiation acted about the same.
What this means, and what it doesn't
What it could mean: This is an early lab finding. It hints that this way of aiming radiation might kill tumor cells just as well, with less of one kind of leftover cell damage. Nothing about your care changes because of this study.
What it doesn't mean: This was done on cells in dishes, not in people. No person was treated in this study. It does not show that grid radiation helps patients live longer or feel better. It is not a cure, and it is not something you can ask for today. Much more research is needed first.
Source: PubMed, September 11, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.